Stonepine Capital, L.P. is 10% Owner at Apollo Endosurgery, Inc. (APEN). They have made 14 open-market trades across 5 companies since 2015, most recently 2021-08-05.
CIK 0001370042
12 open-market purchases totalling $7.4M since 2015, against 2 sales. Across 7 scored buys the stock is up 8.8% at ninety days, and 8.4 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 57% | 71% |
| Avg Move | +3.7% | +0.7% | +8.8% |
| Alpha | +2.3% | -0.0% | +8.4% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVLNF | BUY | 2019-12-10 | 2019-12-12 | $0.69 | $4K | N/A | N/A | N/A |
| NVLNF | BUY | 2019-12-05 | 2019-12-09 | $0.70 | $7K | N/A | N/A | N/A |
| NVLNF | BUY | 2019-11-22 | 2019-11-26 | $0.75 | $135K | N/A | N/A | N/A |
| NVLNF | BUY | 2019-10-11 | 2019-10-16 | $0.65 | $65K | N/A | N/A | N/A |
| APEN | SELL | 2018-12-27 | 2018-12-31 | $3.00 | $750K | -9.6% | +2.9% | +0.0% |
| APEN | SELL | 2018-12-26 | 2018-12-28 | $3.00 | $1.5M | +6.8% | +6.2% | +7.1% |
| APEN | BUY | 2018-11-19 | 2018-11-21 | $3.41 | $196K | +27.3% | -10.5% | -7.4% |
| APEN | BUY | 2018-11-02 | 2018-11-06 | $5.00 | $1.5M | -42.7% | -23.2% | -36.2% |
| APEN | BUY | 2017-12-29 | 2018-01-03 | $5.71 | $195K | +5.3% | -4.8% | +0.2% |
| APEN | BUY | 2017-12-26 | 2017-12-28 | $5.00 | $26K | +9.6% | +6.3% | +10.5% |
| APEN | BUY | 2017-12-20 | 2017-12-22 | $4.88 | $1.4M | +15.4% | +16.9% | +21.9% |
| QLTI | BUY | 2016-09-13 | 2016-09-15 | $1.55 | $389K | +20.5% | +16.7% | +25.0% |
| VIVE | BUY | 2016-06-17 | 2016-06-21 | $5.00 | $1.5M | -9.7% | +3.6% | +48.0% |
| VIVMF | BUY | 2015-11-24 | 2015-11-25 | $0.70 | $2.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.